Join the webinar to hear speakers Prof. Henry Chan, and Assoc. Prof. Teerha Piratvisuth as they discuss the clinical usefulness of PIVKA-II in HCC surveillance, as well as the evidence based practice of first line treatments in unresectable HCC. …
Cancer Type: Liver
Liver Disease in Asia Pacific: Insights from Prof Pierce Chow
In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment….
Liver Disease and Patient Advocacy in Taiwan: Q&A with Prof Yang Pei-Ming
Liver disease is a serious public health issue in Taiwan. The Liver Disease Prevention and Treatment Research Foundation, Taiwan, is one of Asia’s most active and successful patient advocacy groups. Learn from Professor Yang Pei-Ming, CEO of the foundation, about their work and the importance of clinical lab diagnostics to their mission….
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the management of HCC. Learn from Dr Shun Kaneko on Japan’s progress and challenges in HCC management. …
HCC in Thailand: Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment
More than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country. With emerging risk factors, such as alcohol consumption, managing liver disease continues to be a serious challenge for the Thai Ministry of Public Health (MoPH). Learn from Dr Terachai Songkiatkawin, a surgical oncologist and co-president of the MoPH’s cancer service plan, on the policy trends and strategies for improving liver cancer care in Thailand….
Tackling HCV in Punjab: local experts share strategies for success
Punjab is one of Pakistan’s largest provinces and has a particularly high HCV prevalence rate of roughly 9%, compared to 5.4% for Pakistan’s total population. Hear from Prof Ghias Un Nabi Tayyab and Prof Muhammad Umar, two leading experts on HCV in pUnjab, and active participants in Pakistan’s HCV programmes, as they share their perspectives on Punjab’s HCV eradication efforts and solutions for local challenges. …